Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma

Recruiting now · Not applicable

Conditions studied: Glaucoma

In brief

Prospective, multicenter, single-arm study of the iStent infinite in adult pseudophakic or phakic subjects with mild to moderate primary open angle glaucoma who have not failed conventional medical and surgical treatment

Key facts

Study ID

NCT06057051

Run by

Glaukos Corporation

People needed

245

Starts

2023-09-01

Expected to finish

2027-08-01

Last updated by the study team

2023-09-28

Who can join

Age: 35 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of primary open-angle glaucoma
• Phakic or pseudophakic
• Age 35 years or older

You may not qualify if…

• Traumatic, uveitic, neovascular, angle-closure glaucoma or
• glaucoma associated with vascular disorders
• Active corneal inflammation or edema
• Retinal disorders not associated with glaucoma

Where it is running

• Glaukos Investigator Site — Cincinnati, Ohio, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.